The Swiss Stock Exchange made up part of its losses from the previous day on Tuesday in the first exchanges, supported in this endeavor by a positive close of the New York indices. European markets – Zurich included – were dealt a blow on Monday at the end of an electoral weekend which saw a breakthrough by the far right across a good part of the Old Continent.
Eyes are already turning to the Federal Reserve (Fed) of Uncle Sam’s country, which will begin a two-day meeting today at the end of which its main monetary policy committee will deliver its decision on the rate of exchange. interests, but also considerations on the future development of the world’s largest economy.
“The markets should (…) experience high volatility, two days after the European elections and one day before the publication of American inflation and the Fed meeting,” warns John Plassard, of Mirabaud Banque.
At Swissquote, Ipek Ozkardeskaya recalls that hopes of interest rate cuts for the current year have diminished as the readings on American inflation are tougher than expected, in a tense context on the employment front.
In our latitudes, the economic and business agendas were practically blank.
Capital holders therefore immediately relied on analysts and forecasters to guide their investment strategies.
At 9:09 a.m., the Swiss Market Index (SMI) recovered 0.36% to 12,181.69 points, the Swiss Leader Index (SLI) 0.38% to 1980.23 points and the Swiss Performance Index (SPI) 0.30% to 16,162.34 points.
Only four of the thirty main valuations are adorned with red. This motley group included Kühne +Nagel (-0.9%), the good Lindt (-0.7%), Lonza (-0.4%) and SIG Group (-0.2%). The Swisscom defense was right on balance.
The vacuum valve producer VAT Group (+1.8%) attempted an escape, without any particular fuel, pursued by the carrier Swatch (+1.2%) and by Swiss Re (+1.1%). The price target for the Bienne watchmaker was nevertheless the subject of a planing move by Jefferies.
The heavyweights progressed in scattered order, Nestlé nibbling 0.1% while the good Roche gained 0.4% and Novartis 0.6%.
Partners Group (+0.6%) has completed a program worth more than 15 billion francs, the fifth in its history.
On the broader market, the fluid management specialist Sulzer (+0.5%) benefited from price target increases, the day after the presentation of its new roadmap for 2028.
The current prize went to Molecular Partners (+10%), which sees data collected on mice encouraging it to test an experimental anti-cancer drug on humans.
The operator of retail spaces for travelers Avolta (-0.5%) has won a fifteen-year concession at the Sacramento airport.
The cabling machine manufacturer Komax (-2.0%) saw its recommendation changed by Baader Helvea to “add” from “buy”. (AWP)
